Relevant Results
Sorry, there are no results matching your search.
Autocomplete suggestions are available. Use up and down arrows to review and enter to select.
See more results

Latest Trends in M&A and Alternative Deal Structures in the Biopharma Market

CPE 1.0

Webcast

Webcast overview

Join professionals from the KPMG Life Sciences Practice for a webcast that will provide valuable insights into the future state of life sciences investments, with a specific focus on emerging biopharma organizations, as well as the tax implications surrounding these deals.

During this event, we will take a deeper dive into the 2024 life sciences investment outlook, exploring the opportunities and challenges that lie ahead for emerging biopharma companies. Our speakers will share their expertise and provide actionable strategies to navigate the evolving landscape successfully.

Meet our webcast team

Image of Victor Gatti
Victor Gatti
Principal, Tax, KPMG US
Read bio
Image of Martin Mazin
Martin Mazin
Partner, Valuation & Business Modeling Services, KPMG US
Read bio
Image of Alasdair Milton
Alasdair Milton
Principal, Healthcare and Life Sciences Strategy, KPMG US
Read bio
Image of Victor Gatti
Victor Gatti
Principal, Tax, KPMG US
Read bio
Image of Martin Mazin
Martin Mazin
Partner, Valuation & Business Modeling Services, KPMG US
Read bio
Image of Alasdair Milton
Alasdair Milton
Principal, Healthcare and Life Sciences Strategy, KPMG US
Read bio

Explore more

Insight
Webcast Replay Webcast Upcoming Listen Now From The Web

2024 Healthcare and Life Sciences Investment Outlook

We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.

Read more
Healthcare and life sciences M&A: Poised for a rebound?
Insight
Webcast Replay Webcast Upcoming Listen Now From The Web

Healthcare and life sciences M&A: Poised for a rebound?

After a wild few years for HCLS, there’s reason for optimism and some new opportunities—if you know where to look.

Read more

KPMG Life Sciences CEO Outlook

Exploring CEO views on the economy, disruptive technology and ESG

Facing pricing pressures, patent expirations and rising R&D costs, life sciences CEOs expect slower growth over the next three years. Based on research from KPMG, this article finds that sector CEOs are exploring opportunities to boost their trajectory using new technologies such as generative AI – supported by a stronger digital foundation. At the same time, appetite for M&A remains strong with many CEOs saying they will make strategic deals when markets stabilize.
Read more

Explore other services

Service
Tax Services
Read more
Industry
Life Sciences
Read more
Service
Mergers & acquisitions tax and valuations
Read more
Service
Deal Advisory and Strategy
Read more

KPMG. Make the Difference.


Some or all of the services described herein may not be permissible for KPMG audit clients and their affiliates or related entities.

The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act upon such information without appropriate professional advice after a thorough examination of the particular situation. KPMG LLP does not provide legal services.

The information contained herein is not intended to be “written advice concerning one or more Federal tax matters” subject to the requirements of section 10.37(a)(2) of Treasury Department Circular 230.

© 2025 KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's . Privacy Statement

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Search now!

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Submit

Office locations

View locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Learn more

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.

Contact

Headline